With the price of iron being high relative to the last quarter, I expect a healthy increase in revenue and profit to be reported in the next quarter.Probably worth holding on for a couple more months
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
